Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |